Global and China Viral Detection Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Viral Detection Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Plaque Assays
  • 1.2.3 PCR
  • 1.2.4 ELISA
  • 1.2.5 Others
• 1.3 Market by Application
  • 1.3.1 Global Viral Detection Market Share by Application: 2020 VS 2026
  • 1.3.2 Blood & Blood Products
  • 1.3.3 Cellular & Gene Therapy Products
  • 1.3.4 Stem Cell Products
  • 1.3.5 Tissue & Tissue Products
  • 1.3.6 Vaccines and Therapeutics
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Viral Detection Market Perspective (2015-2026)
• 2.2 Global Viral Detection Growth Trends by Regions
  • 2.2.1 Viral Detection Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Viral Detection Historic Market Share by Regions (2015-2020)
  • 2.2.3 Viral Detection Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Viral Detection Players by Market Size
  • 3.1.1 Global Top Viral Detection Players by Revenue (2015-2020)
  • 3.1.2 Global Viral Detection Revenue Market Share by Players (2015-2020)
• 3.2 Global Viral Detection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Viral Detection Revenue
• 3.4 Global Viral Detection Market Concentration Ratio
  • 3.4.1 Global Viral Detection Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Viral Detection Revenue in 2019
• 3.5 Key Players Viral Detection Area Served
• 3.6 Key Players Viral Detection Product Solution and Service
• 3.7 Date of Enter into Viral Detection Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Viral Detection Breakdown Data by Type (2015-2026)

• 4.1 Global Viral Detection Historic Market Size by Type (2015-2020)
• 4.2 Global Viral Detection Forecasted Market Size by Type (2021-2026)

5 Viral Detection Breakdown Data by Application (2015-2026)

• 5.1 Global Viral Detection Historic Market Size by Application (2015-2020)
• 5.2 Global Viral Detection Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Viral Detection Market Size (2015-2026)
• 6.2 North America Viral Detection Market Size by Type (2015-2020)
• 6.3 North America Viral Detection Market Size by Application (2015-2020)
• 6.4 North America Viral Detection Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Viral Detection Market Size (2015-2026)
• 7.2 Europe Viral Detection Market Size by Type (2015-2020)
• 7.3 Europe Viral Detection Market Size by Application (2015-2020)
• 7.4 Europe Viral Detection Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Viral Detection Market Size (2015-2026)
• 8.2 China Viral Detection Market Size by Type (2015-2020)
• 8.3 China Viral Detection Market Size by Application (2015-2020)
• 8.4 China Viral Detection Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Viral Detection Market Size (2015-2026)
• 9.2 Japan Viral Detection Market Size by Type (2015-2020)
• 9.3 Japan Viral Detection Market Size by Application (2015-2020)
• 9.4 Japan Viral Detection Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Viral Detection Market Size (2015-2026)
• 10.2 Southeast Asia Viral Detection Market Size by Type (2015-2020)
• 10.3 Southeast Asia Viral Detection Market Size by Application (2015-2020)
• 10.4 Southeast Asia Viral Detection Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Avance Biosciences Inc. (U.S.)
  • 11.1.1 Avance Biosciences Inc. (U.S.) Company Details
  • 11.1.2 Avance Biosciences Inc. (U.S.) Business Overview
  • 11.1.3 Avance Biosciences Inc. (U.S.) Viral Detection Introduction
  • 11.1.4 Avance Biosciences Inc. (U.S.) Revenue in Viral Detection Business (2015-2020))
  • 11.1.5 Avance Biosciences Inc. (U.S.) Recent Development
• 11.2 BSL BIOSERVICE (Germany)
  • 11.2.1 BSL BIOSERVICE (Germany) Company Details
  • 11.2.2 BSL BIOSERVICE (Germany) Business Overview
  • 11.2.3 BSL BIOSERVICE (Germany) Viral Detection Introduction
  • 11.2.4 BSL BIOSERVICE (Germany) Revenue in Viral Detection Business (2015-2020)
  • 11.2.5 BSL BIOSERVICE (Germany) Recent Development
• 11.3 Clean Cells (France)
  • 11.3.1 Clean Cells (France) Company Details
  • 11.3.2 Clean Cells (France) Business Overview
  • 11.3.3 Clean Cells (France) Viral Detection Introduction
  • 11.3.4 Clean Cells (France) Revenue in Viral Detection Business (2015-2020)
  • 11.3.5 Clean Cells (France) Recent Development
• 11.4 Charles River Laboratories International, Inc. (U.S.)
  • 11.4.1 Charles River Laboratories International, Inc. (U.S.) Company Details
  • 11.4.2 Charles River Laboratories International, Inc. (U.S.) Business Overview
  • 11.4.3 Charles River Laboratories International, Inc. (U.S.) Viral Detection Introduction
  • 11.4.4 Charles River Laboratories International, Inc. (U.S.) Revenue in Viral Detection Business (2015-2020)
  • 11.4.5 Charles River Laboratories International, Inc. (U.S.) Recent Development
• 11.5 Lonza Group (Switzerland)
  • 11.5.1 Lonza Group (Switzerland) Company Details
  • 11.5.2 Lonza Group (Switzerland) Business Overview
  • 11.5.3 Lonza Group (Switzerland) Viral Detection Introduction
  • 11.5.4 Lonza Group (Switzerland) Revenue in Viral Detection Business (2015-2020)
  • 11.5.5 Lonza Group (Switzerland) Recent Development
• 11.6 Merck KGaA (Germany)
  • 11.6.1 Merck KGaA (Germany) Company Details
  • 11.6.2 Merck KGaA (Germany) Business Overview
  • 11.6.3 Merck KGaA (Germany) Viral Detection Introduction
  • 11.6.4 Merck KGaA (Germany) Revenue in Viral Detection Business (2015-2020)
  • 11.6.5 Merck KGaA (Germany) Recent Development
• 11.7 Sigma-Aldrich Corporation (U.S.)
  • 11.7.1 Sigma-Aldrich Corporation (U.S.) Company Details
  • 11.7.2 Sigma-Aldrich Corporation (U.S.) Business Overview
  • 11.7.3 Sigma-Aldrich Corporation (U.S.) Viral Detection Introduction
  • 11.7.4 Sigma-Aldrich Corporation (U.S.) Revenue in Viral Detection Business (2015-2020)
  • 11.7.5 Sigma-Aldrich Corporation (U.S.) Recent Development
• 11.8 SGS S.A. (Switzerland)
  • 11.8.1 SGS S.A. (Switzerland) Company Details
  • 11.8.2 SGS S.A. (Switzerland) Business Overview
  • 11.8.3 SGS S.A. (Switzerland) Viral Detection Introduction
  • 11.8.4 SGS S.A. (Switzerland) Revenue in Viral Detection Business (2015-2020)
  • 11.8.5 SGS S.A. (Switzerland) Recent Development
• 11.9 Texcell, Inc. (France)
  • 11.9.1 Texcell, Inc. (France) Company Details
  • 11.9.2 Texcell, Inc. (France) Business Overview
  • 11.9.3 Texcell, Inc. (France) Viral Detection Introduction
  • 11.9.4 Texcell, Inc. (France) Revenue in Viral Detection Business (2015-2020)
  • 11.9.5 Texcell, Inc. (France) Recent Development
• 11.10 WuXi PharmaTech (Cayman) Inc. (China)
  • 11.10.1 WuXi PharmaTech (Cayman) Inc. (China) Company Details
  • 11.10.2 WuXi PharmaTech (Cayman) Inc. (China) Business Overview
  • 11.10.3 WuXi PharmaTech (Cayman) Inc. (China) Viral Detection Introduction
  • 11.10.4 WuXi PharmaTech (Cayman) Inc. (China) Revenue in Viral Detection Business (2015-2020)
  • 11.10.5 WuXi PharmaTech (Cayman) Inc. (China) Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer